Physician profile
Carmen Christine Simler
NPI 1750965471
$1,314.11
in general payments reported to CMS, 2019-2025
15 companies · $25.62 in 2025
The $25.62 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $421 · 2022: $115 · 2023: $244 · 2024: $509 · 2025: $25.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $678 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $678.16 |
| Education | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $276.38 | 2021-2025 | Farxiga |
| Ardelyx, INC. | $240.69 | 2024 | Xphozah 30 Mg, Ibsrela |
| Glaxosmithkline, LLC. | $124.74 | 2023 | Jesduvroq |
| Aurinia Pharma U.S., INC. | $116.44 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $115.24 | 2024 | Jynarque |
| Calliditas Therapeutics US INC. | $110.70 | 2024 | |
| Opko Pharmaceuticals, LLC | $100.00 | 2023 | Rayaldee |
| Mallinckrodt Hospital Products INC. | $97.48 | 2022 | |
| Travere Therapeutics, INC. | $28.17 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.54 | 2021 | |
| Vifor Pharma, INC. | $19.23 | 2023 | Korsuva, Veltassa |
| Amag Pharmaceuticals, INC. | $18.54 | 2021 | |
| Amgen INC. | $17.60 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.77 | 2024 | Jardiance |
| Akebia Therapeutics INC | $12.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carmen Simler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.